Prof. Diana Eccles on POSH trial: 'BRCA carriers identified soon after diagnosis have a similar prognosis to those who do not have a BRCA mutation - it is key to treat the cancer on merit before worrying about future risks' #UKIBCS
#UKIBCS "In 5 years, 90% of #breastcancer patients with high risk of recurrence should reach a pathologic complete response without without chemo." -
@DrLauraEsserman